Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Outlines Plans to Progress NCX 4251 into Phase 2b Trial Following Positive Meeting with FDA

April 8, 2020

View Press Release Corporate presentation Contact us
Previous